BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 4633144)

  • 21. [Undesirable effects of gold therapy].
    Rainer F
    Wien Klin Wochenschr Suppl; 1984; 156():40-4. PubMed ID: 6442056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of gold lymphocyte binding during chrysotherapy.
    Lorber A; Wilcox S; Leeb J; Simon T
    J Rheumatol; 1979; 6(3):270-6. PubMed ID: 114635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of gold salts in the treatment of rheumatoid arthritis in a group of our patients].
    Vitaus M; Androić S; Car A
    Reumatizam; 1977; 24(5):161-3. PubMed ID: 412242
    [No Abstract]   [Full Text] [Related]  

  • 24. Organic gold compounds in the treatment of rheumatoid arthritis.
    Rooney TW; Furst DE
    Iowa Med; 1985 Feb; 75(2):74-7. PubMed ID: 3918952
    [No Abstract]   [Full Text] [Related]  

  • 25. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)].
    Slobodina GA
    Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chrysotherapy and side effects (author's transl)].
    Eberl R
    Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pulmonary toxicity associated with treatment by gold salts].
    Ballesteros JA; Maimó A; Usandizaga I; Orfila J
    Med Clin (Barc); 1995 Jan; 104(2):78-9. PubMed ID: 7869784
    [No Abstract]   [Full Text] [Related]  

  • 30. [The studies of the gold therapy (Solganal-B oleosum) on rheumatoid arthritis].
    Nagano S; Kuwahara M; Mitsuishi M; Kimura C; Shimizu C
    Kumamoto Igakkai Zasshi; 1969 May; 43(5):458-65. PubMed ID: 5820097
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Eosinophilia during gold therapy.
    Jessop JD; Dippy J; Turnbull A; Bright M
    Rheumatol Rehabil; 1974 May; 13(2):75-80. PubMed ID: 4276506
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
    Porter DR; Capell HA; Hunter J
    J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. A prospective investigation.
    de Bosset PL; Biter T
    Schweiz Med Wochenschr; 1973 Aug; 103(33):1153-8. PubMed ID: 4201618
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():51-5. PubMed ID: 114649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanisms of action of conventional chrysotherapy.
    Bluhm GB
    J Rheumatol Suppl; 1982; 8():10-7. PubMed ID: 6813472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy.
    Kirkham BW; Davison SC; Corkill MM; Barbatis C; Panayi GS
    J Rheumatol; 1993 Jun; 20(6):935-9. PubMed ID: 8350327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gold salts and rheumatoid polyarthritis. Preliminary results of a retrospective survey].
    Boasson M; Bernat M; Renier JC
    Rhumatologie; 1972 Apr; 24(4):115-21. PubMed ID: 5077712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.